Home / News / Event #1099225 SEC EDGAR published this disclosure on 2026-09-08. Read the original document for its full text and supporting detail.
Open the original document at SEC EDGAR ↗ accession 0002109966-26-000006
acquired disposed A
code M
direct or indirect D
form 4
is derivative false
issuer name NovaBridge Biosciences
label Exercise of derivative
Source record & verification Dates, provenance and technical details
Context links are based on the recorded entity type Recorded payload Structured source data
Recorded payload JSON payload as stored after parsing {
"accession": "0002109966-26-000006",
"acquired_disposed": "A",
"code": "M",
"direct_or_indirect": "D",
"form": "4",
"is_derivative": false,
"issuer_name": "NovaBridge Biosciences",
"label": "Exercise of derivative",
"person_name": "Cao Sean Wuxiong",
"price": null,
"role": "Chief Bus. Development Officer",
"security": "Ordinary Shares",
"shares": 104236,
"shares_owned_after": 374445,
"source_path": "edgar/data/2109966/0002109966-26-000006.txt",
"ticker": "NBP",
"transaction_date": "2026-09-03",
"value": null
}
Evidence-based analysis facts, provenance and explicit model coverage Descriptive evidence from the stored source record; it is not advice, a forecast or a legal conclusion.